Finance

Beta
Lists
MYCOF:OTCMKTS
Noveris Health Sciences Inc
$1.08
0.00%
(0.00) 1D
May 22, 10:01:10 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MYCOF...
Mkt. cap
119.44M
Avg. vol.
764.00
Volume
0.00
52-wk high
$1.40
52-wk low
$0.10
Beta
8.96
Shares outstanding
58.55M
No. of employees
3
Mkt. cap
119.44M
Avg. vol.
764.00
Volume
0.00
52-wk high
$1.40
52-wk low
$0.10
Beta
8.96
Shares outstanding
58.55M
No. of employees
3
News stories
From sources across the web
About Noveris Health Sciences Inc
CEO-
Employees3
Founded2013
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-40.14K
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
371.31K
243.28K
-70.57K
5.04K
Operating expense
371.31K
243.28K
-110.70K
5.04K
Total operating expenses
371.31K
243.28K
-110.70K
5.04K
Operating income
-371.31K
-243.28K
110.70K
-5.04K
Other non operating income
-2.82K
-28.66K
85.53K
-417.63K
EBT including unusual items
-298.86K
-12.95K
73.79K
3.16M
EBT excluding unusual items
-494.91K
-133.43K
73.79K
-405.27K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-298.86K
-12.95K
73.79K
3.16M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-140.60K
-140.46K
-
-26.16K
Net interest expenses
-140.60K
-140.46K
-
-26.16K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more